$ZYME 4 SEC Filings

Filed On	Filing
09 Oct 2026	Form 4: Schayowitz Adam, EVP, Head of R&D Received 37,037 shares by exercise or conversion · Sold 13,832 shares ($358K)
06 Jul 2026	Form 4: Hollywood Mark, EVP & Chief Operating Officer Received 939 shares as a grant or award ($20.9K)
15 May 2026	Form 4: Schneider Paul R, EVP, General Counsel Granted 178,000 Stock Option (Right to Buy) · Granted 119,000 Restricted Stock Unit
10 Apr 2026	Form 4: Platshon Scott, EVP, Chief Business Officer Granted 70,000 Stock Option (Right to Buy) · Granted 47,000 Restricted Stock Unit · Granted 76,000 Performance Stock Unit
10 Apr 2026	Form 4: Schayowitz Adam, See Remarks Granted 70,000 Stock Option (Right to Buy) · Granted 47,000 Restricted Stock Unit · Granted 76,000 Performance Stock Unit
07 Apr 2026	Form 4: Stafford Kristin, EVP, Chief Financial Officer Granted 178,000 Stock Option (Right to Buy) · Granted 169,000 Restricted Stock Unit
13 Jan 2026	Form 4: Hollywood Mark, EVP & Chief Operating Officer Received 17,666 shares by exercise or conversion · Sold 6,120 shares ($139K) · Granted 70,000 Stock Option (Right to Buy) · 2 more
13 Jan 2026	Form 4: Cherry Brian N, Director Granted 23,000 Stock Option (Right to Buy) · Granted 15,400 Restricted Stock Unit
12 Jan 2026	Form 4: Ciongoli Gregory Austin, Director Granted 11,500 Stock Option (Right to Buy) · Granted 7,700 Restricted Stock Unit
12 Jan 2026	Form 4: Cesano Alessandra, Director Granted 11,500 Stock Option (Right to Buy) · Granted 7,700 Restricted Stock Unit
12 Jan 2026	Form 4: Landry Robert E, Director Granted 11,500 Stock Option (Right to Buy) · Granted 7,700 Restricted Stock Unit
12 Jan 2026	Form 4: Neu Kelvin, Director Granted 11,500 Stock Option (Right to Buy) · Granted 7,700 Restricted Stock Unit
12 Jan 2026	Form 4: Smith Jeffrey T L, EVP & Chief Medical Officer Received 17,666 shares by exercise or conversion · Sold 9,310 shares ($211K)
12 Jan 2026	Form 4: Campoy Carlos, Director Granted 11,500 Stock Option (Right to Buy) · Granted 7,700 Restricted Stock Unit
12 Jan 2026	Form 4: Mahony Susan, Director Granted 11,500 Stock Option (Right to Buy) · Granted 7,700 Restricted Stock Unit
12 Jan 2026	Form 4: Moore Paul Andrew, Chief Scientific Officer Received 17,666 shares by exercise or conversion · Sold 9,560 shares ($217K) · Granted 70,000 Stock Option (Right to Buy) · 2 more
12 Jan 2026	Form 4: Galbraith Kenneth, Director Received 64,000 shares by exercise or conversion · Sold 30,424 shares ($690K) · Granted 216,000 Stock Option (Right to Buy) · 2 more
07 Jan 2026	Form 4: Patterson Leone D, EVP, Chief Bus & Fin Officer Received 459 shares as a grant or award ($4.84K)
05 Jan 2026	Form 4: Smith Jeffrey T L, EVP & Chief Medical Officer Received 20,000 shares by exercise or conversion · Sold 10,538 shares ($264K)
05 Jan 2026	Form 4: Galbraith Kenneth, Director Received 114,334 shares by exercise or conversion · Sold 54,343 shares ($1.36M)

Comments